Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet(®)), sustained‐release carbidopa‐levodopa (Sinemet(®) CR), and carbidopa‐levodopa‐entacapone (Stalevo(®))

IPX066 (extended‐release carbidopa‐levodopa [ER CD‐LD]) is an oral extended‐release capsule formulation of carbidopa and levodopa. The single‐dose pharmacokinetics of ER CD‐LD (as 2 capsules; total dose, 97.5 mg‐390 mg CD‐LD) versus immediate‐release (IR) CD‐LD (25 mg‐100 mg), sustained‐release (CR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Ann, Yao, Hsuan‐Ming, Gupta, Suneel, Modi, Nishit B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Pharmacokinetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032972/
https://www.ncbi.nlm.nih.gov/pubmed/25855267
http://dx.doi.org/10.1002/jcph.514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032972/
https://www.ncbi.nlm.nih.gov/pubmed/25855267
http://dx.doi.org/10.1002/jcph.514

Ejemplares similares